A New International Healthcare Sustainability Certification
Are you a healthcare organization accelerating your sustainable practices and seeking formal recognition?
Discover how Joint Commission International (JCI) and the Geneva Sustainable Centre (GSC) can support you on your journey toward sustainable healthcare.
For more information, please scan the QR code.
Publisher
Arab Health Media Communication
President Simon Chammas schammas@tahmag.com
Executive Vice President Mirna Khairallah mirna@tahmag.com
Editor in Chief Simon Semaan
Senior Director of Content Marketing Jessie Chlela jessie@tahmag.com
Senior Editor Elham Najem
Editors
May Atallah, Adel Abdel Karim Najib Zein, Dany Khairallah
Creative Director Rania Khalil rania@tahmag.com
Business Development Manager Wadih Chammas wadih@tahmag.com
IT Manager Elie Yammine elie@tahmag.com
Photographer Hanna Nehme
Advertising advertising@thearabhospital.com
OFFICES
IHMC, Cyprus +357 96 158661
Dubai Expert Media Communication Services-FZCO
Dubai Silicone Oasis +971 50 2971007
Printing
Distribution
KSA - UAE - OMAN - TURKEY
LEBANON - JORDAN - KUWAIT
BAHRAIN - QATAR - EGYPT
images from shutterstock© unless provided by clients.
E xcell ence i n He al t hc a r e
Ceda r s -S i n ai ha s been nam e d t o t h e H o nor R o ll f o r th e ninth cons e cut i v e y ea r i n
U. S. News & World Repor t ’s “ Be s t H o s pi t al s 2024 – 25” r a n ki n g s . A s a globa l le a de r
i n he al t h ca re , w e o f f e r a ful l r a ng e o f s e r vic es to pat i en t s f ro m a ro und t h e w o r ld . Wh e th e r w e’ re p ro vid i ng cl i nical se r vic es in y ou r re gion vi a vid e o vi s i ts or at ou r
ren o wn ed m e d i ca l c e nte r, o u r mis s ion re main s uncha n ged: to gi v e p at ien ts acc e s s
t o exc el l en ce i n h ea lthca re w h e re v e r th e y may be. L oca te d in i conic B e v er ly Hill s ,
Ceda r s -S in ai bl e nds cu t ti n g - edg e medicin e in a vib r a nt s e t ting k n o w n f o r it s r ic h
cultu re, f a mou s l a n dm a r ks a nd y e a r- round wa rm w e ath e r—makin g it a l e adin g
d e s ti n a ti o n f o r i n t e rn a ti o nal pa t i e nt s se e k ing w orld - cl a s s t re atmen t .
ACIBADEM UNIVERSITY
trains healthcare students to be future healthcare professionals.
ACIBADEM LABMED
offers a wide range of services including pathology, food control, stem cell and cord blood bank within the laboratory framework.
develops turnkey hospital establishment projects.
Plasma-SeqSensei™
The Plasma-SeqSensei Breast Cancer IVD Kit is an NGSbased liquid biopsy assay that focuses on highly sensitive detection of clinically relevant mutations in TP53, ESR1, PIK3CA, AKT1 and ERBB2 from blood plasma.
Learn more about the unique advantages of Plasma-SeqSensei technology
The Plasma-SeqSensei Breast Cancer IVD Kit is an NGSbased liquid biopsy assay that focuses on highly sensitive detection of clinically relevant mutations in TP53, ESR1, PIK3CA, AKT1 and ERBB2 from blood plasma.
High sensitivity at low MAFs
Learn more about the unique advantages of Plasma-SeqSensei technology
Down to 0.06% - 0.07% Mutant Allele Fractions.
High sensitivity at low MAFs
Down to 0.06% - 0.07% Mutant Allele Fractions.
Absolute quantification
Short and standardised workflow
From cfDNA samples to results in two days.
Short and standardised workflow
From cfDNA samples to results in two days.
Data analysis and reporting made easy
Generate report designed for clinicians with just a few clicks.
Absolute quantification
Meaningful comparison of ctDNA levels per millilitre of plasma.
Expert voices
Meaningful comparison of ctDNA levels per millilitre of plasma.
Data analysis and reporting made easy
Generate report designed for clinicians with just a few clicks.
Expert voices
‘We know that tissue samples cannot be taken regularly, but liquid biopsy is easy to take, it is simply a sample of blood. And it gives you real-time information.’
Dr
‘Even low levels of ctDNA could have given an indication of the coming progression in the follow-up.’
‘There is much more diagnostic power in the absolute quantification.’
Bhuwnesh Agrawal Member of The Supervisory Board Sysmex Inostics and MD, Germany
‘We know that tissue samples cannot be taken regularly, but liquid biopsy is easy to take, it is simply a sample of blood. And it gives you real-time information.’
Dr Bhuwnesh Agrawal
Member of The Supervisory Board
Prof. Christopher Gebhardt
‘Even low levels of ctDNA could have given an indication of the coming progression in the follow-up.’
UKE Hamburg, Germany
Prof. Christopher Gebhardt UKE Hamburg, Germany
‘There is much more diagnostic power in the absolute quantification.’
Prof. Geert A. Martens
AZ
Delta General Hospital, Belgium
Prof. Geert A. Martens AZ Delta General Hospital, Belgium
For more information, visit www.sysmex-mea.com/liquidbiopsy
Sysmex Inostics and MD, Germany
www.cmc.com.lb
www.cmc.com.lb
Post-Congress Workshop: 7th May 2025
Radisson Blu Hotel Jeddah Al Salam Jeddah, Kingdom of Saudi Arabia
Dr. Walid Fitaihi Founder, Chairman of the Board of Directors, and Chief Executive Officer International Medical Center (IMC)
Dr. Wael Khattab Executive Director Corporate Operations and Patient Experience Magrabi Health
Dr. Ahmed S. Alamri Group Chief Executive Officer
Dr. Samir Abbas Healthcare Group
Sandeep Dhupar Chief Executive Officer FASSCO International
Marcelo Pereira Chief Executive Officer Oman International Hospital
Vita Steina Global Council, Board Member, Fellow at The Beryl Institute Advisor, The Health Minister of Latvia Chair, Patient Experience Association Latvia
Dr. Saeed Yami Chief Quality & Patient Safety Officer Johns Hopkins Aramco Healthcare (JHAH)
Dr. Kathy Sienko Executive Director, Nursing Affairs King Faisal Specialist Hospital & Research Centre
Qadar Zada Chief Operating Officer International Medical Center (IMC)
Dr. Majeda Afeef Al-Ruzzieh
Chief Nursing Officer, Chairperson Patient Centered Care Committee King Hussein Cancer Center
Prof. Ahmed Hersi Chief Executive Officer King Saud University Medical City
Dr. Khulood Alsayegh Head of Clinical Standards and Guidelines Section Health Policies and Standard Department Dubai Health Authority
Dr. Reem F. Bunyan Chief Executive Officer Value in Health
Dr. Maryam AlQaseer Vice President of Quality and Performance Eastern Health Cluster
Two-Day Summit: 12th & 13th May 2025
PX Initiative Awards: 13th May 2025
Post-Congress Workshop: 14th May 2025 Riyadh – Kingdom of Saudi Arabia
Organised By
Dr. Saleh Altamimi Chief Executive Officer Riyadh First Health Cluster
Marcelo Pereira Chief Executive Officer Oman International Hospital
Dr. Walid Fitaihi Chairman of the Board of Directors, and Chief Executive Officer International Medical Center (IMC)
Dr. Laura Cooley Editor In Chief Journal of Patient Experience
Dr. Mohammed G. Alghamdi Director General of Nursing Ministry of Health, KSA President Saudi Nurses Association
David Boucher Chief Executive Officer Bumrungrad International Hospital Phuket & Market
